Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

Cell | Jul 23, 2009

The evolution of prostate cancer from an androgen-dependent state to one that is androgen-independent marks its lethal progression. The androgen receptor (AR) is essential in both, though its function in androgen-independent cancers is poorly understood. We have defined the direct AR-dependent target genes in both androgen-dependent and -independent cancer cells by generating AR-dependent gene expression profiles and AR cistromes. In contrast to what is found in androgen-dependent cells, AR selectively upregulates M-phase cell-cycle genes in androgen-independent cells, including UBE2C, a gene that inactivates the M-phase checkpoint. We find that epigenetic marks at the UBE2C enhancer, notably histone H3K4 methylation and FoxA1 transcription factor binding, are present in androgen-independent cells and direct AR-enhancer binding and UBE2C activation. Thus, the role of AR in androgen-independent cancer cells is not to direct the androgen-dependent gene expression program without androgen, but rather to execute a distinct program resulting in androgen-independent growth.

Pubmed ID: 19632176 RIS Download

Mesh terms: Androgens | Cell Division | Cell Line, Tumor | Gene Expression Regulation, Neoplastic | Hepatocyte Nuclear Factor 3-alpha | Histones | Humans | Male | Prostatic Neoplasms | Receptors, Androgen | Transcriptional Activation | Ubiquitin-Conjugating Enzymes

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

Associated grants

  • Agency: NCI NIH HHS, Id: P50 CA090381
  • Agency: NCI NIH HHS, Id: P50 CA090381-060005
  • Agency: NCI NIH HHS, Id: K99 CA126160
  • Agency: NCI NIH HHS, Id: P50CA090381
  • Agency: NCI NIH HHS, Id: K99 CA129565
  • Agency: NCI NIH HHS, Id: P50 CA090381-070005
  • Agency: NCI NIH HHS, Id: K99 CA129565-01A1

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.